Greenwood to step down as CEO of BIO after 2020 election by Nick Paul Taylor Wednesday, October 9, 2019 Jim Greenwood will make way for a new leader who will work to “defend innovation from domestic political attacks.”
Senate approves $2B boost for NIH in $850B+ spending bill by Amirah Al Idrus Friday, August 24, 2018 The Senate approved a spending package that includes a $2 billion boost that increases NIH funding to $39.1 billion for fiscal year 2019.
In defiance of Trump, Senate poised to boost NIH funding—again by Amirah Al Idrus Tuesday, August 21, 2018 Ignoring President Donald Trump’s proposed budget, the Senate is debating a $2 billion boost in funding for the NIH.
Right-to-try is designed to weaken the FDA, law’s author says by Nick Paul Taylor Friday, June 1, 2018 The author of right-to-try legislation is pressuring Scott Gottlieb, M.D., to implement the law in a way that weakens the FDA.
Message to Trump: Alnylam CEO proud to be a ‘shitholer’ by Phil Taylor Monday, January 15, 2018 Describing a country as a “shithole” isn’t going to endear you to anyone, but President Trump’s latest alleged outburst has struck a nerve with one particular biotech leader.
Medtronic asks U.S. House to change device plant inspections by Amirah Al Idrus Friday, May 5, 2017 Pat Shrader, Medtronic’s VP for global regulatory affairs, urged Congress to “improve” the inspection of medical device manufacturing facilities.
Congress ignores Trump, agrees to $2B boost to NIH budget by Phil Taylor Monday, May 1, 2017 President Trump's push for a reduction in the NIH budget came to nothing last night as Congress instead increased it by $2 billion.
